Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry
Methods are provided for determining the amount of an IGF-I and/or IGF-II protein in a sample using high resolution/high accuracy mass spectrometry. The methods generally comprise enriching an IGF-I and/or IGF-II protein in a sample, ionizing an IGF-I and/or IGF-II protein from the sample to generate IGF-I and/or IGF-II protein ions, and determining the amount of IGF-I and/or IGF-II protein ions with high resolution/high accuracy mass spectrometry.
1. A method for determining an amount of insulin-like growth factor-II (IGF-II) protein in a sample, the method comprising:
a. ionizing IGF-II in the sample to produce one or more ions detectable by mass sspectrometry;
b. determining the amount of one or more of the ions comprising an ion with a mass-to-charge ratio selected from a group consisting of 934.69±2, 1068.07±2, 1245.92±2, and 1494.89±2 by mass spectrometry; and
c. determining the amount of the IGF-II in the sample using the amount of the one or more ions determined in step b.
2. The method of claim 1 , wherein the method does not include digesting the protein prior to ionization.
3. The method of claim 1 , wherein the method comprises acid ethanol extraction.
4. The method of claim 1 , wherein the mass spectrometry is conducted with a mass analyzer capable of a full width at half maximum (FWHM) of greater than or equal to 10,000 and an accuracy of less than or equal to 50 ppm.
5. The method of claim 4 , wherein with-the mass analyzer is a time of flight mass analyzer capable of a FWHM of greater than or equal to 20,000 and an accuracy of less than or equal to 10 ppm.
6. The method of claim 1 , wherein the method further comprises determining an amount of insulin-like growth factor-I (IGF-I).
7. The method of claim 1 , further comprising chemically modifying the protein, prior to ionization, to reduce number of disulfide bridges in the protein.
8. The method of claim 1 , further comprising purifying the protein with solid phase extraction (SPE) prior to ionization.
9. The method of claim 1 , further comprising purifying the protein by high performance liquid chromatography (HPLC) prior to ionization.
10. The method of claim 1 , wherein the sample comprises plasma or serum.
11. The method of claim 1 , wherein the one or more ions used to determine the amount of the IGF-II protein further comprise one or more ions selected from a group of ions with a mass to charge ratio of 1067.36±0.1, 1067.51±0.1, 1067.65±0.1, 1067.80±0.1, 1067.94±0.1, 1068.08±0.1, 1068.23±0.1, 1068.37±0.1, 1068.51±0.1, 1068.65±0.1, 1068.80±0.1, 1068.94±0.1, and 1069.08±0.1.